Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InMode Ltd. stock logo
INMD
InMode
$15.16
-0.4%
$14.33
$13.14
$19.85
$958.25M1.951.23 million shs595,953 shs
Envista Holdings Corporation stock logo
NVST
Envista
$20.39
+1.1%
$18.26
$14.22
$23.00
$3.46B12.50 million shs1.00 million shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$59.00
+1.4%
$57.97
$47.04
$103.81
$3.20B1.07843,675 shs229,134 shs
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$86.64
+0.5%
$77.90
$40.67
$87.16
$4.37B-2.63791,444 shs330,112 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InMode Ltd. stock logo
INMD
InMode
0.00%+6.80%+5.68%-3.53%-13.30%
Envista Holdings Corporation stock logo
NVST
Envista
0.00%+3.58%+9.12%+31.80%+25.09%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.00%+3.67%-9.30%+15.17%-7.26%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
0.00%+4.07%+15.18%+28.39%+106.13%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
InMode Ltd. stock logo
INMD
InMode
3.3658 of 5 stars
3.13.00.00.03.21.71.9
Envista Holdings Corporation stock logo
NVST
Envista
3.7745 of 5 stars
2.23.00.03.82.90.01.9
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.4088 of 5 stars
3.41.00.00.02.42.50.6
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
4.4478 of 5 stars
3.52.00.04.63.22.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InMode Ltd. stock logo
INMD
InMode
2.13
Hold$18.5422.35% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.33
Hold$20.23-0.78% Downside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.86
Moderate Buy$90.0052.54% Upside
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3.09
Buy$107.1023.62% Upside

Current Analyst Ratings Breakdown

Latest INMD, SLNO, PRCT, and NVST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/23/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$110.00
5/27/2025
Envista Holdings Corporation stock logo
NVST
Envista
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
5/27/2025
Envista Holdings Corporation stock logo
NVST
Envista
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$21.00 ➝ $23.00
5/8/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$81.00 ➝ $97.00
5/8/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$102.00 ➝ $105.00
5/5/2025
Envista Holdings Corporation stock logo
NVST
Envista
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$21.00 ➝ $18.00
5/2/2025
Envista Holdings Corporation stock logo
NVST
Envista
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$21.00
4/30/2025
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$29.00 ➝ $24.00
4/30/2025
Envista Holdings Corporation stock logo
NVST
Envista
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.00 ➝ $17.00
4/29/2025
InMode Ltd. stock logo
INMD
InMode
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$19.00 ➝ $16.25
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InMode Ltd. stock logo
INMD
InMode
$394.82M2.43$1.82 per share8.31$10.12 per share1.50
Envista Holdings Corporation stock logo
NVST
Envista
$2.51B1.38$1.66 per share12.27$17.05 per share1.20
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$224.50M14.54N/AN/A$7.71 per share7.65
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/A$5.68 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InMode Ltd. stock logo
INMD
InMode
$181.27M$2.336.508.33N/A44.79%17.17%15.20%7/30/2025 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
-$1.12B-$6.53N/A16.851.30-44.90%4.07%2.25%8/6/2025 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$91.41M-$1.70N/AN/AN/A-36.20%-28.09%-20.02%7/30/2025 (Estimated)
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$175.85M-$4.62N/AN/AN/AN/A-77.52%-63.44%8/6/2025 (Estimated)

Latest INMD, SLNO, PRCT, and NVST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$1.14-$0.95+$0.19-$0.95N/AN/A
5/1/2025Q1 2025
Envista Holdings Corporation stock logo
NVST
Envista
$0.20$0.24+$0.04$0.10$608.17 million$616.90 million
4/28/2025Q1 2025
InMode Ltd. stock logo
INMD
InMode
$0.45$0.31-$0.14$0.26$82.21 million$77.87 million
4/24/2025Q1 2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.49-$0.45+$0.04-$0.45$65.39 million$69.16 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InMode Ltd. stock logo
INMD
InMode
N/A
8.73
7.86
Envista Holdings Corporation stock logo
NVST
Envista
0.43
2.12
1.82
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.13
8.95
7.75
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
0.21
19.64
19.64

Institutional Ownership

CompanyInstitutional Ownership
InMode Ltd. stock logo
INMD
InMode
68.04%
Envista Holdings Corporation stock logo
NVST
Envista
N/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
97.42%

Insider Ownership

CompanyInsider Ownership
InMode Ltd. stock logo
INMD
InMode
6.92%
Envista Holdings Corporation stock logo
NVST
Envista
1.30%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
6.60%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
6.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
InMode Ltd. stock logo
INMD
InMode
48063.21 million58.84 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,300169.49 million167.28 millionOptionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43055.33 million51.68 millionOptionable
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3050.39 million47.17 millionOptionable

Recent News About These Companies

SLNO Soleno Therapeutics, Inc. - Seeking Alpha

New MarketBeat Followers Over Time

Media Sentiment Over Time

InMode stock logo

InMode NASDAQ:INMD

$15.16 -0.06 (-0.36%)
Closing price 07/3/2025 03:31 PM Eastern
Extended Trading
$15.16 +0.01 (+0.03%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Envista stock logo

Envista NYSE:NVST

$20.39 +0.22 (+1.09%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$20.42 +0.03 (+0.15%)
As of 07/3/2025 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$59.00 +0.82 (+1.41%)
Closing price 07/3/2025 03:40 PM Eastern
Extended Trading
$58.40 -0.60 (-1.02%)
As of 07/3/2025 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Soleno Therapeutics stock logo

Soleno Therapeutics NASDAQ:SLNO

$86.64 +0.43 (+0.49%)
Closing price 07/3/2025 02:34 PM Eastern
Extended Trading
$86.64 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.